Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study

被引:8
|
作者
Dam, V [1 ,2 ,3 ]
Dobson, A. J. [1 ]
Onland-Moret, N. C. [2 ]
van der Schouw, Y. T. [2 ]
Mishra, G. D. [1 ]
机构
[1] Univ Queensland, Sch Publ Hlth, 266 Herston Rd, Brisbane, Qld 4006, Australia
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[3] Netherlands Heart Inst, Moreelsepk 1, NL-3511 EP Utrecht, Netherlands
基金
澳大利亚国家健康与医学研究理事会;
关键词
Cardiovascular disease; Cerebrovascular disease; Coronary heart disease; Vasomotor menopausal symptoms; HOT FLASHES; HORMONE-THERAPY; MORTALITY; FLUSHES;
D O I
10.1016/j.maturitas.2019.12.011
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To ascertain the association between vasomotor menopausal symptoms (VSM), hot flushes and night sweats, and cardiovascular disease, coronary heart disease and cerebrovascular disease. Study design: The study sample comprised 8881 women (aged 45-50 years) with available hospital separation data from the 1946-51 cohort (1996-2016) of the ongoing Australian Longitudinal Study on Women's Health, a national prospective cohort study. Main outcome measures: First fatal or non-fatal cardiovascular disease, coronary heart disease, and cerebrovascular disease events were obtained through linkage with hospital admission data, the National Death Index, and Medicare Benefits Schedule. Hot flushes and night sweats were assessed via questionnaires at each main survey. Additionally, we calculated the duration of symptoms based on whether or not women reported vasomotor menopausal symptoms in each survey. Results: There were 925 cardiovascular disease, 484 coronary heart disease and 154 cerebrovascular disease events. There was no consistent evidence of any association with vasomotor menopausal symptoms, hot flushes and night sweats. We did find marginally statistically significant associations between presence of night sweats and cardiovascular disease (Hazard Ratio = 1.18, 95 % Confidence Interval: 1.01-1.38), and between the duration of vasomotor menopausal symptoms [years] and coronary heart disease (Hazard Ratio(per year) = 1.03, 95 % Confidence Interval: 1.00-1.05). However, given the number of associations tested, these findings could very well have arisen by chance. Conclusion: In this large longitudinal study with 20 years of follow-up and clinical outcomes we did not find a convincing association between vasomotor menopausal symptoms, hot flushes, night sweats and cardiovascular disease, coronary heart disease and cerebrovascular disease.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 50 条
  • [31] Vasomotor Symptoms and Risk of Cardiovascular Disease Events in the Study of Women's Health Across the Nation
    Thurston, Rebecca C.
    Vlachos, Helen
    Derby, Carol A.
    Matthews, Karen
    Brooks, Maria
    Jackson, Elizabeth
    Harlow, Siobhan
    Joffe, Hadine
    El Khoudary, Samar R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (12): : 1450 - 1450
  • [32] Effects of insomnia and non-vasomotor menopausal symptoms on coronary heart disease risk: a mendelian randomization study
    Lian, Ie-Bin
    Sie, Jia Jyun
    Chang, Chia-Chu
    Fann, Cathy S. J.
    Huang, Ching-Hui
    HELIYON, 2023, 9 (02)
  • [33] Migraines, vasomotor symptoms, and cardiovascular disease in the Coronary Artery Risk Development in Young Adults study
    Kim, Catherine
    Schreiner, Pamela J.
    Yin, Zhe
    Whitney, Rachael
    Sidney, Stephen
    Ebong, Imo
    Levine, Deborah A.
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (03): : 202 - 208
  • [34] Vasomotor menopausal symptoms and cardiovascular risk factors: a systematic review and meta-analysis of the current evidence
    Begbie, R.
    Lumsden, M. A.
    Thurston, R.
    Mishra, G.
    Hickey, M.
    Iliodromiti, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 181 - 181
  • [35] A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
    Kapoor, Ekta
    Faubion, Stephanie
    Hurt, Ryan T.
    Fischer, Karen
    Schroeder, Darrell
    Fokken, Shawn
    Croghan, Ivana T.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (11): : 1228 - 1235
  • [36] Menopausal Vasomotor Symptoms and Plasma Alzheimer's Disease Biomarkers
    Thurston, Rebecca C.
    Maki, Pauline
    Chang, Yuefang
    Wu, Minjie
    Aizenstein, Howard
    Derby, Carol A.
    Karikari, Thomas K.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1262 - 1262
  • [37] Is it WISE to link vasomotor symptoms with cardiovascular disease?
    Stuenkel, Cynthia A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (02): : 121 - 123
  • [38] Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?
    Biglia, N.
    Cagnacci, A.
    Gambacciani, M.
    Lello, S.
    Maffei, S.
    Nappi, R. E.
    CLIMACTERIC, 2017, 20 (04) : 306 - 312
  • [39] The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition
    Randolph, JF
    Sowers, MF
    Bondarenko, I
    Gold, EB
    Greendale, GA
    Bromberger, JT
    Brockwell, SE
    Matthews, KA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11): : 6106 - 6112
  • [40] The reciprocal relationship between menopausal symptoms and depressive symptoms: A 9-year longitudinal study of American women in midlife
    Strauss, Judy R.
    MATURITAS, 2011, 70 (03) : 302 - 306